Companies / Ovid Therapeutics Inc.

Ovid Therapeutics Inc.

Nasdaq: OVIDCIK 1636651NEW YORK, NY

Financials · FY2025

Revenue$7.25M
Net income$-17.41M
Total debt—
Cash$11.33M
Diluted EPS$-0.74
Shares outstanding195.3M

Ownership

195.3M shares outstanding · as of Aug 11, 2026
2.1%Insiders
Ownership
Insiders2.14%4,179,478
Institutions50.84%99,290,160
Public float47.02%91,828,219

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Jeremy M. LevinExecutive Chairman · Director
1.91%3,735,048
Papadopoulos SteliosDirector
0.11%217,578
Rona Jeffrey ACBFO
0.08%156,313
Alexander Margaret a.CEOPresident and CEO · Director
0.03%61,750
Friedman BartDirector
<0.01%8,789
Bernstein KarenDirector
——
Duncan Barbara GayleDirector
——
Fitzgerald Kevin JosephFormerDirector
——

Institutional holders 92

View all →
HolderValue% of shares
BlackRock, Inc.$29.12M5.54%
RA Capital Management, L.P.$23.79M5.49%
Janus Henderson Group PLC$23.73M5.49%
State Street Corporation$21.25M4.05%
Adage Capital Partners Gp, L.L.C.$13.68M3.16%
Balyasny Asset Management L.P.$12.28M2.83%
Affinity Asset Advisors, LLC$11.65M3.66%
Federated Hermes Inc$7.93M1.83%
ADAR1 Capital Management, LLC$6.98M2.19%
Eventide Asset Management, LLC$6.98M2.19%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 23, 2026Jeremy M. Levin
Executive
ExerciseCommon Stock$66.3K+47K
+1.28%
3,735,048
1.91% of shares
low
Apr 7, 2026Papadopoulos Stelios
Director
GrantCommon Stock$45.0K+18K
+8.79%
217,578
0.11% of shares
low
Apr 7, 2026Friedman Bart
Director
GrantCommon Stock$22.5K+9K
8,789
<0.01% of shares
low
Feb 23, 2026Alexander Margaret a.
CEO
SellCommon Stock$16.9K-12K
-15.88%
61,750
0.03% of shares
low
Feb 23, 2026Rona Jeffrey A
Executive
SellCommon Stock$12.4K-9K
-8.83%
88,188
0.05% of shares
low
Feb 26, 2026Rona Jeffrey A
Executive
GrantCommon Stock$0+68K
+77.25%
156,313
0.08% of shares
low
Feb 26, 2026Bernstein Karen
Director
GrantEmployee Stock Option (Right to Buy)—+65K
65,000
0.03% of shares
low
Mar 23, 2026Jeremy M. Levin
Executive
ExerciseSeries A Warrant (right to buy)—-47K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Federated Hermes IncPassive13G———
Point72 Asset Management, L.P.Passive13G———
Affinity Asset Advisors, LLCPassive13G/A———
ADAR1 Capital Management, LLCPassive13G———
Balyasny Asset Management L.P.Passive13G———
Jeremy M. LevinPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OVID——690469101—